Ways and Means takes its turn on drug shortages

A key question behind chronic drug shortages is what policy levers Congress could use to mitigate Americans not being able to get the drugs they need. The problem is acute for lower-priced generics with manufacturers blaming supply-chain issues and innumerable regulations. Fill out the form to read the full article.